{"slideshow_credits": null, "snippet": "Readers discuss the benefits and drawbacks of using buprenorphine for opioid addiction.", "abstract": null, "section_name": "Opinion", "print_page": "24", "document_type": "article", "byline": [], "web_url": "http://www.nytimes.com/2013/11/19/opinion/a-lifesaving-treatment-and-a-killer.html", "lead_paragraph": "Readers discuss the benefits and drawbacks of using buprenorphine for opioid addiction.", "headline": {"main": "A Lifesaving Treatment, and a Killer", "print_headline": "A Lifesaving Treatment, and a Killer", "content_kicker": "Letters", "kicker": "Letters"}, "_id": "528ab24638f0d833dcdee992", "word_count": "701", "multimedia": [{"height": 126, "url": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-thumbWide.jpg", "legacy": {"wideheight": "126", "wide": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-thumbWide.jpg", "widewidth": "190"}, "subtype": "wide", "width": 190, "type": "image"}, {"height": 746, "url": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-articleLarge.jpg", "legacy": {"xlarge": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-articleLarge.jpg", "xlargewidth": "600", "xlargeheight": "746"}, "subtype": "xlarge", "width": 600, "type": "image"}, {"height": 75, "url": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-thumbStandard.jpg", "legacy": {"thumbnail": "images/2013/11/19/opinion/1119LETTERS/1119LETTERS-thumbStandard.jpg", "thumbnailwidth": "75", "thumbnailheight": "75"}, "subtype": "thumbnail", "width": 75, "type": "image"}], "pub_date": "2013-11-19T00:00:00Z", "source": "The New York Times", "news_desk": "Letters", "keywords": [{"value": "Drug Abuse and Traffic", "name": "subject", "is_major": "N", "rank": "3"}, {"value": "Buprenorphine (Drug)", "name": "subject", "is_major": "N", "rank": "1"}, {"value": "Addiction (Psychology)", "name": "subject", "is_major": "N", "rank": "2"}, {"value": "Doctors", "name": "subject", "is_major": "N", "rank": "4"}], "blog": [], "subsection_name": null, "type_of_material": "Letter"}